Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Fabrication of Graphene Nanoplatelet-Incorporated Porous Hydroxyapatite Composites: Improved Mechanical and in Vivo Imaging Performances for Emerging Biomedical Applications.

Kumar S, Gautam C, Mishra VK, Chauhan BS, Srikrishna S, Yadav RS, Trivedi R, Rai SB.

ACS Omega. 2019 Apr 24;4(4):7448-7458. doi: 10.1021/acsomega.8b03473. eCollection 2019 Apr 30.

2.

Logic gate behavior and intracellular application of a fluorescent molecular switch for the detection of Fe3+ and cascade sensing of F- in pure aqueous media.

Dwivedi R, Singh DP, Singh S, Singh AK, Chauhan BS, Srikrishna S, Singh VP.

Org Biomol Chem. 2019 Aug 28;17(32):7497-7506. doi: 10.1039/c9ob01398a. Epub 2019 Jul 31.

PMID:
31365007
3.

Management dilemma in case of a posterior mediastinal paraganglioma.

Bohra DV, Srikrishna SV, Kaskar A.

Asian Cardiovasc Thorac Ann. 2019 Sep;27(7):612-615. doi: 10.1177/0218492319862703. Epub 2019 Jul 8. No abstract available.

PMID:
31284725
4.

Classification of Clinical Isolates of Klebsiella pneumoniae Based on Their in vitro Biofilm Forming Capabilities and Elucidation of the Biofilm Matrix Chemistry With Special Reference to the Protein Content.

Singh AK, Yadav S, Chauhan BS, Nandy N, Singh R, Neogi K, Roy JK, Srikrishna S, Singh RK, Prakash P.

Front Microbiol. 2019 Apr 4;10:669. doi: 10.3389/fmicb.2019.00669. eCollection 2019.

5.

GABA mediated reduction of arsenite toxicity in rice seedling through modulation of fatty acids, stress responsive amino acids and polyamines biosynthesis.

Kumar N, Gautam A, Dubey AK, Ranjan R, Pandey A, Kumari B, Singh G, Mandotra S, Chauhan PS, Srikrishna S, Dutta V, Mallick S.

Ecotoxicol Environ Saf. 2019 May 30;173:15-27. doi: 10.1016/j.ecoenv.2019.02.017. Epub 2019 Feb 10.

PMID:
30743076
6.

Antioxidant, antimicrobial and cytotoxic potential of silver nanoparticles synthesized using flavonoid rich alcoholic leaves extract of Reinwardtia indica.

Upadhyay P, Mishra SK, Purohit S, Dubey GP, Singh Chauhan B, Srikrishna S.

Drug Chem Toxicol. 2019 Jan;42(1):65-75. doi: 10.1080/01480545.2018.1488859. Epub 2018 Jul 22.

PMID:
30033778
7.

scribble (scrib) knockdown induces tumorigenesis by modulating Drp1-Parkin mediated mitochondrial dynamics in the wing imaginal tissues of Drosophila.

Yadav AK, Srikrishna S.

Mitochondrion. 2019 Jan;44:103-110. doi: 10.1016/j.mito.2018.01.006. Epub 2018 Jan 31.

PMID:
29360576
8.

Pulpal Response to Ferric Sulfate and Diode Laser When Used as Pulpotomy Agent: An In vivo Study.

Sivadas S, Rao A, Natarajan S, Shenoy R, Srikrishna SB.

J Clin Diagn Res. 2017 Jun;11(6):ZC87-ZC91. doi: 10.7860/JCDR/2017/25180.10121. Epub 2017 Jun 1.

9.

Knockdown of APPL mimics transgenic Aβ induced neurodegenerative phenotypes in Drosophila.

Singh SK, Srivastav S, Yadav AK, Srikrishna S.

Neurosci Lett. 2017 May 1;648:8-13. doi: 10.1016/j.neulet.2017.03.030. Epub 2017 Mar 20.

PMID:
28336338
10.

Assessment of the impact of urogenital prolapse on sexual dysfunction.

Rantell A, Srikrishna S, Robinson D.

Maturitas. 2016 Oct;92:56-60. doi: 10.1016/j.maturitas.2016.07.001. Epub 2016 Jul 21. Review.

PMID:
27621239
11.

Cancer Drug Development Using Drosophila as an in vivo Tool: From Bedside to Bench and Back.

Yadav AK, Srikrishna S, Gupta SC.

Trends Pharmacol Sci. 2016 Sep;37(9):789-806. doi: 10.1016/j.tips.2016.05.010. Epub 2016 Jun 10. Review.

PMID:
27298020
12.

Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds.

Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G.

Oxid Med Cell Longev. 2016;2016:7361613. doi: 10.1155/2016/7361613. Epub 2015 Dec 28. Review.

13.
14.

Novel targeted bladder drug-delivery systems: a review.

Zacchè MM, Srikrishna S, Cardozo L.

Res Rep Urol. 2015 Nov 23;7:169-78. doi: 10.2147/RRU.S56168. eCollection 2015. Review.

15.

Digital assessment and quantification of pelvic organ prolapse (DPOP-Q): a randomised cross-over diagnostic agreement trial.

Thiagamoorthy G, Zacchè M, Cardozo L, Naidu M, Giarenis I, Flint R, Srikrishna S, Robinson D.

Int Urogynecol J. 2016 Mar;27(3):433-7. doi: 10.1007/s00192-015-2841-3. Epub 2015 Sep 30.

PMID:
26423265
16.

Drug therapy for an overactive bladder.

Thiagamoorthy G, Cardozo L, Srikrishna S.

Womens Health (Lond). 2015 Jul;11(4):445-8. doi: 10.2217/whe.15.31. Epub 2015 Aug 4. No abstract available.

PMID:
26238677
17.

Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4' benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulations.

Kumar A, Srivastava S, Tripathi S, Singh SK, Srikrishna S, Sharma A.

J Biomol Struct Dyn. 2016 Jun;34(6):1252-63. doi: 10.1080/07391102.2015.1074943. Epub 2015 Oct 19.

PMID:
26208790
18.

Patient and surgeon goal achievement 10 years following surgery for pelvic organ prolapse and urinary incontinence.

Srikrishna S, Robinson D, Cardozo L, Thiagamoorthy G.

Int Urogynecol J. 2015 Nov;26(11):1679-86. doi: 10.1007/s00192-015-2760-3. Epub 2015 Jun 20.

PMID:
26089082
19.

Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson's Disease.

Srivastav S, Singh SK, Yadav AK, Srikrishna S.

Neurochem Res. 2015 Jul;40(7):1350-9. doi: 10.1007/s11064-015-1598-x. Epub 2015 May 12.

PMID:
25963948
20.

Sexual function after urinary incontinence surgery.

Thiagamoorthy G, Srikrishna S, Cardozo L.

Maturitas. 2015 Jun;81(2):243-7. doi: 10.1016/j.maturitas.2015.03.002. Epub 2015 Mar 11. Review.

PMID:
25899565
21.

Folic acid supplementation rescues anomalies associated with knockdown of parkin in dopaminergic and serotonergic neurons in Drosophila model of Parkinson's disease.

Srivastav S, Singh SK, Yadav AK, Srikrishna S.

Biochem Biophys Res Commun. 2015 May 8;460(3):780-5. doi: 10.1016/j.bbrc.2015.03.106. Epub 2015 Mar 27.

PMID:
25824034
22.

Highly sensitive cell imaging "Off-On" fluorescent probe for mitochondria and ATP.

Srivastava P, Razi SS, Ali R, Srivastav S, Patnaik S, Srikrishna S, Misra A.

Biosens Bioelectron. 2015 Jul 15;69:179-85. doi: 10.1016/j.bios.2015.02.028. Epub 2015 Feb 19.

PMID:
25727034
23.

Community based maternal death review: lessons learned from ten districts in Andhra Pradesh, India.

Singh S, Murthy GV, Thippaiah A, Upadhyaya S, Krishna M, Shukla R, Srikrishna SR.

Matern Child Health J. 2015 Jul;19(7):1447-54. doi: 10.1007/s10995-015-1678-1.

PMID:
25636651
24.

Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu(II)/Zn(II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and cell imaging studies.

Alizadeh R, Yousuf I, Afzal M, Srivastav S, Srikrishna S, Arjmand F.

J Photochem Photobiol B. 2015 Feb;143:61-73. doi: 10.1016/j.jphotobiol.2014.12.027. Epub 2015 Jan 6.

PMID:
25600265
25.

Nuclear blebbing of biologically active organoselenium compound towards human cervical cancer cell (HeLa): in vitro DNA/HSA binding, cleavage and cell imaging studies.

Rizvi MA, Zaki M, Afzal M, Mane M, Kumar M, Shah BA, Srivastav S, Srikrishna S, Peerzada GM, Tabassum S.

Eur J Med Chem. 2015 Jan 27;90:876-88. doi: 10.1016/j.ejmech.2014.12.014. Epub 2014 Dec 10.

PMID:
25535953
26.

Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies.

Tabassum S, Zaki M, Ahmad M, Afzal M, Srivastav S, Srikrishna S, Arjmand F.

Eur J Med Chem. 2014 Aug 18;83:141-54. doi: 10.1016/j.ejmech.2014.06.018. Epub 2014 Jun 10.

PMID:
24953031
27.

Management of prolapse in older women.

Thiagamoorthy G, Cardozo L, Srikrishna S, Toozs-Hobson P, Robinson D.

Post Reprod Health. 2014 Mar;20(1):30-35. Epub 2014 Mar 13. Review.

PMID:
24879778
28.

The flavonoid derivative 2-(4' Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against Aβ42-induced neurodegeneration in transgenic Drosophila: insights from in silico and in vivo studies.

Singh SK, Gaur R, Kumar A, Fatima R, Mishra L, Srikrishna S.

Neurotox Res. 2014 Nov;26(4):331-50. doi: 10.1007/s12640-014-9466-z. Epub 2014 Apr 5.

PMID:
24706035
29.

Quality assurance in quality of life assessment--measuring the validity of the King's Health Questionnaire.

Vij M, Srikrishna S, Robinson D, Cardozo L.

Int Urogynecol J. 2014 Aug;25(8):1133-5. doi: 10.1007/s00192-014-2370-5. Epub 2014 Mar 26.

PMID:
24667983
30.

Fesoterodine fumarate and the oxybutynin ring for the treatment of urinary incontinence in women.

Rantell A, Cardozo L, Srikrishna S.

Expert Opin Pharmacother. 2014 Feb;15(3):385-93. doi: 10.1517/14656566.2014.875158. Epub 2013 Dec 27. Review.

PMID:
24369895
31.

The value of vaginal packing in pelvic floor surgery: a randomised double-blind study.

Thiagamoorthy G, Khalil A, Cardozo L, Srikrishna S, Leslie G, Robinson D.

Int Urogynecol J. 2014 May;25(5):585-91. doi: 10.1007/s00192-013-2264-y. Epub 2013 Dec 6.

PMID:
24310987
32.

Important drug–drug interactions for treatments that target overactive bladder syndrome.

Srikrishna S, Robinson D, Cardozo L.

Int Urogynecol J. 2014 Jun;25(6):715-20. Review.

PMID:
24232071
33.

Neuroprotective Role of a Novel Copper Chelator against Aβ 42 Induced Neurotoxicity.

Singh SK, Sinha P, Mishra L, Srikrishna S.

Int J Alzheimers Dis. 2013;2013:567128. doi: 10.1155/2013/567128. Epub 2013 Sep 18.

34.

Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.

Tabassum S, Asim A, Khan RA, Hussain Z, Srivastav S, Srikrishna S, Arjmand F.

Dalton Trans. 2013 Dec 28;42(48):16749-61. doi: 10.1039/c3dt51209f. Epub 2013 Sep 27.

PMID:
24077532
35.

DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl)phenyldipyrromethene.

Gupta RK, Pandey R, Sharma G, Prasad R, Koch B, Srikrishna S, Li PZ, Xu Q, Pandey DS.

Inorg Chem. 2013 Apr 1;52(7):3687-98. doi: 10.1021/ic302196v. Epub 2013 Mar 11.

PMID:
23477351
36.

Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?

Giarenis I, Mastoroudes H, Srikrishna S, Robinson D, Cardozo L.

BJU Int. 2013 Aug;112(4):501-7. doi: 10.1111/j.1464-410X.2012.11652.x. Epub 2013 Mar 4.

37.

Lower urinary tract symptoms in women with benign joint hypermobility syndrome: a case-control study.

Mastoroudes H, Giarenis I, Cardozo L, Srikrishna S, Vella M, Robinson D, Kazkaz H, Grahame R.

Int Urogynecol J. 2013 Sep;24(9):1553-8. doi: 10.1007/s00192-013-2065-3. Epub 2013 Feb 23.

PMID:
23436036
38.

Radiation exposure during videourodynamics in women.

Giarenis I, Phillips J, Mastoroudes H, Srikrishna S, Robinson D, Lewis C, Cardozo L.

Int Urogynecol J. 2013 Sep;24(9):1547-51. doi: 10.1007/s00192-013-2062-6. Epub 2013 Feb 22.

PMID:
23430076
39.

Prolapse and sexual function in women with benign joint hypermobility syndrome.

Mastoroudes H, Giarenis I, Cardozo L, Srikrishna S, Vella M, Robinson D, Kazkaz H, Grahame R.

BJOG. 2013 Jan;120(2):187-192. doi: 10.1111/1471-0528.12082.

40.

The vagina as a route for drug delivery: a review.

Srikrishna S, Cardozo L.

Int Urogynecol J. 2013 Apr;24(4):537-43. doi: 10.1007/s00192-012-2009-3. Epub 2012 Dec 11. Review.

PMID:
23229421
41.

Use of near infrared spectroscopy as an alternative to videourodynamics to detect detrusor overactivity in women with the overactive bladder syndrome.

Mastoroudes H, Giarenis I, Vella M, Srikrishna S, Robinson D, Cardozo L, Karrouze I, Campbell A, Macnab A.

Urology. 2012 Sep;80(3):547-50. doi: 10.1016/j.urology.2012.05.036. Epub 2012 Jul 26.

PMID:
22840868
42.

Role of composite endpoints as an outcome assessment tool in urogenital prolapse.

Srikrishna S, Robinson D, Cardozo L.

J Obstet Gynaecol. 2012 Apr;32(3):276-9. doi: 10.3109/01443615.2011.653594.

PMID:
22369404
43.

Interstitial cystitis: diagnosis and management.

Vij M, Srikrishna S, Cardozo L.

Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):1-7. doi: 10.1016/j.ejogrb.2011.12.014. Epub 2012 Feb 4. Review.

PMID:
22310942
44.

Validity and reliability of patient selected goals as an outcome measure in overactive bladder.

Cartwright R, Srikrishna S, Cardozo L, Robinson D.

Int Urogynecol J. 2011 Jul;22(7):841-7. doi: 10.1007/s00192-011-1360-0. Epub 2011 Jan 29.

PMID:
21279328
45.

Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder.

Cartwright R, Srikrishna S, Cardozo L, Robinson D.

BJU Int. 2011 May;107(10):1612-7. doi: 10.1111/j.1464-410X.2010.09684.x. Epub 2010 Nov 11.

46.

A longitudinal study of patient and surgeon goal achievement 2 years after surgery following pelvic floor dysfunction surgery.

Srikrishna S, Robinson D, Cardozo L.

BJOG. 2010 Nov;117(12):1504-11. doi: 10.1111/j.1471-0528.2010.02705.x.

47.

Ringing the changes in evaluation of urogenital prolapse.

Srikrishna S, Robinson D, Cardozo L.

Int Urogynecol J. 2011 Feb;22(2):171-5. doi: 10.1007/s00192-010-1253-7. Epub 2010 Sep 7. Erratum in: Int Urogynecol J Pelvic Floor Dysfunct. 2011 Jul;22(7):901.

PMID:
20821310
48.

Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.

Cartwright R, Srikrishna S, Cardozo L, Robinson D.

BJU Int. 2011 Jan;107(1):70-6. doi: 10.1111/j.1464-410X.2010.09508.x.

49.

Can sex survive pelvic floor surgery?

Srikrishna S, Robinson D, Cardozo L, Gonzalez J.

Int Urogynecol J. 2010 Nov;21(11):1313-9. doi: 10.1007/s00192-010-1198-x. Epub 2010 Jun 25.

PMID:
20577716
50.

Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse.

Srikrishna S, Robinson D, Cardozo L.

Int Urogynecol J. 2010 May;21(5):523-8. doi: 10.1007/s00192-009-1069-5. Epub 2009 Dec 15.

PMID:
20013110

Supplemental Content

Loading ...
Support Center